MAYO CLINIC ROCHESTER
Project 2
Project 2 is a funding opportunity from MAYO CLINIC ROCHESTER, up to 274101, closing August 31, 2030.
Aug 31, 2030
(1492d left)Overview
ABSTRACT – ALLFTD2: PROJECT 2 Approximately 70% of FTLD cases are sporadic (s-FTLD) and have no clear genetic or other identifiable cause. Like familial FTLD (f-FTLD), s-FTLD is uniformly fatal and there are no approved treatments. The most common s-FTLD syndrome is sporadic behavioral variant frontotemporal…